Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
B 3.42 -0.58% -0.02
MYO closed down 0.58 percent on Thursday, April 25, 2024, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 8
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish -0.58%
Wide Bands Range Expansion -0.58%
Overbought Stochastic Strength -0.58%
Upper Bollinger Band Touch Strength -0.58%
NR7 Range Contraction -3.39%
Stochastic Reached Overbought Strength -3.39%
Overbought Stochastic Strength -3.39%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 11 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Down 2 % about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myomo Inc. Description

Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Disability Robotics Neurological Disorders Stroke Multiple Sclerosis Amyotrophic Lateral Sclerosis Prosthetics Nerve Urological Disorders Orthopedics Podiatry Spinal Cord Skeletal System Neurotrauma

Is MYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.5799
52 Week Low 0.371
Average Volume 268,287
200-Day Moving Average 2.48
50-Day Moving Average 3.28
20-Day Moving Average 3.10
10-Day Moving Average 3.11
Average True Range 0.27
RSI (14) 55.56
ADX 11.82
+DI 29.78
-DI 24.11
Chandelier Exit (Long, 3 ATRs) 2.84
Chandelier Exit (Short, 3 ATRs) 3.31
Upper Bollinger Bands 3.57
Lower Bollinger Band 2.64
Percent B (%b) 0.84
BandWidth 29.81
MACD Line 0.00
MACD Signal Line -0.08
MACD Histogram 0.0741
Fundamentals Value
Market Cap 95.32 Million
Num Shares 27.9 Million
EPS -0.49
Price-to-Earnings (P/E) Ratio -6.98
Price-to-Sales 5.49
Price-to-Book 9.30
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.65
Resistance 3 (R3) 3.63 3.53 3.61
Resistance 2 (R2) 3.53 3.48 3.54 3.59
Resistance 1 (R1) 3.48 3.44 3.51 3.50 3.58
Pivot Point 3.38 3.38 3.40 3.39 3.38
Support 1 (S1) 3.33 3.33 3.36 3.35 3.26
Support 2 (S2) 3.23 3.29 3.24 3.25
Support 3 (S3) 3.18 3.23 3.23
Support 4 (S4) 3.20